FibroGen Inc (MEX:FGEN)
MXN 6.4 -0.01 (-0.16%) Market Cap: 598.78 Mil Enterprise Value: 711.97 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 44/100

FibroGen Inc at Bank of America Global Research Healthcare Conference (Virtual) - Fireside Chat Transcript

May 13, 2021 / 09:00PM GMT
Release Date Price: MXN427.78
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Good evening, everybody, and thanks for joining us at the Bank of America Annual Healthcare Conference being conducted virtually this year. Hopefully, next year -- the CDC just gave us the mask-free mandate. So hopefully, next year, we'll be able to do this in Las Vegas.

This is our final fireside chat of a 3-day event, and I'm pleased to be introducing our next company presenter, FibroGen and CEO Enrique Conterno. So Enrique, thanks for joining us.

Enrique A. Conterno
FibroGen, Inc. - CEO & Director

Jason, thank you very much for the invitation. I'm looking forward to the chat.

Questions & Answers

Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Yes. Maybe just kicking things off, maybe just talk a little bit about what drew you to FibroGen. You're coming from Eli Lilly, intimately involved in diabetes, large markets, the primary asset, roxadustat also being something

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot